Pulmonary Vein Isolation: Comparing different energy sources - independent or complementary use?

Area of Science:

• Cardiology
• Electrophysiology
• Medical Devices

Background:

• Atrial fibrillation (AF) treatment often involves pulmonary vein isolation (PVI).
• Conventional thermal ablation (radiofrequency and cryoablation) carries risks and procedural complexities.
• Pulsed-field ablation (PFA) is a novel non-thermal modality for PVI.

Purpose of the Study:

• To compare pulsed-field ablation (PFA) with conventional thermal ablation for pulmonary vein isolation (PVI).
• To evaluate the efficacy, safety, and limitations of PFA in atrial fibrillation treatment.
• To explore the potential role of PFA in conjunction with thermal ablation for comprehensive cardiac lesioning.

Main Methods:

• Review of randomized controlled trials and large registries comparing PFA with RF and cryoablation.
• Analysis of PFA's mechanism of action: irreversible electroporation of cardiomyocytes.
• Evaluation of clinical outcomes including procedural time, efficacy, and adverse events.

Main Results:

• PFA demonstrates shorter procedural times and comparable/superior efficacy for paroxysmal AF PVI.
• PFA significantly reduces risks of esophageal injury, phrenic nerve palsy, and pulmonary vein stenosis.
• PFA limitations include hemolysis, coronary vasospasm, need for deep sedation, and uncertain durability of non-PVI lesions.

Conclusions:

• PFA is a promising energy source for PVI, offering safety and efficiency advantages.
• Thermal ablation remains essential for lesions beyond the pulmonary veins, such as the mitral and cavotricuspid isthmuses.
• Combined RF and PFA strategies are under investigation to enhance lesion durability and create comprehensive cardiac lesions.